D-1130-2023 Class II Terminated
FDA drug recall D-1130-2023 was initiated by Central Admixture Pharmacy Services, Inc. on August 17, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles The recall status is terminated (terminated March 27, 2025). Affected quantity: 292 bags..
Recall Details
- Product Type
- Drugs
- Report Date
- September 6, 2023
- Initiation Date
- August 17, 2023
- Termination Date
- March 27, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 292 bags.
Product Description
EPINEPHrine added to 0.9% sodium chloride, 4mg/250mL (16 mcg/mL), IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-8093-1.
Reason for Recall
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Distribution Pattern
Nationwide in the USA
Code Information
Lot# 36-260047, Exp 10/3/2023. ;